In an industry projected to have substantial growth within next few years, Veritas is among the first to apply a comprehensive scientific approach behind medical marijuana claims. Our mission is to develop the most effective cannabis strains for specific disease conditions, and to provide doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence.
Veritas Pharma is currently publicly traded in three countries
Canada
CSE: VRT
U.S.
OTC: VRTHF
Germany
FRT: 2VP
Securities Attorney
Richards Buell Sutton LLP
401 W Georgia St.
Vancouver, BC V6B 5A1
Phone: (604) 682-3664
Patent Attorney
Oyen Wiggs Green & Mutala LLP
480 – The Station
601 West Cordova Street
Vancouver, British Columbia
Canada V6B 1G1
Phone: 604.669.3432
Transfer Agent
Computershare Trust Co of Canada
510 Burrard Street
Vancouver, British Columbia
Canada V6C 3A8
Phone: 604.661.9400
Auditor
Saturna Group Chartered Accountants LLP
1250–1066 West Hastings St.
Vancouver, BC V6E 3X1
T: 604-630-5100
Investor Relations
Sam Eskandari
T: +1 (416) 918-6785
E: ir@veritaspharmainc.com